|
受注:045-509-1970 |
技術サポート:tech@selleck.co.jp 平日9:00〜18:00 1営業日以内にご連絡を差し上げます |
|
Synonyms | N/A | Storage (From the date of receipt) |
3 years -20°C powder 1 years -80°C in solvent |
| 化学式 | C35H36F3N3O4 |
|||
| 分子量 | 619.67 | CAS No. | 880635-03-0 | |
| Solubility (25°C)* | 体外 | DMSO | 100 mg/mL (161.37 mM) | |
| Ethanol | 20 mg/mL (32.27 mM) | |||
| Water | Insoluble | |||
|
* <1 mg/ml means slightly soluble or insoluble. * Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
||||
| 製品説明 | GW 6471は、IC50が0.24 μMのPPARαの強力なアンタゴニストです。 |
|---|---|
| in vitro | GW6471 completely inhibits GW409544-induced activation of PPARα with IC50 of 0.24 μM. This compound at concentration ranging from 0.001-10 μM disrupts the interactions between PPAR and coactivator motifs derived from SRC-1 or CBP, but promotes the binding of the co-repressor motifs from SMRT or N-CoR. It adopts a U-shaped configuration and wraps around C276 of helix 3, destroys the integrity of the charge clamp but leaves sufficient space to accommodate the additional helical turn of the co-repressor motif in the PPAR/GW6471/SMRT complexes. This chemical at concentration of 10 μM significantly prevents cardiomyocyte differentiation and results in the reduced expression of cardiac sarcomeric proteins (ie α-actinin, troponin-T) and specific genes (ie α-MHC, MLC2v) in a time-dependent manner through inhibiting PPARα. |
| in vivo | GW6471 is a potent PPARα antagonist. |
| キナーゼアッセイ | Binding assays | |
|---|---|---|
| The effects of GW6471 on the interaction of coactivator and co-repressor peptides with PPAR are determined by chemical-mediated fluorescence energy transfer assays. The experiments are conducted with 5 nM PPARα LBD of biotinylated peptide containing individual motifs , following the manufacturer | ||
| 細胞アッセイ | 細胞株 | Cell-free assays |
| 濃度 | 0.24 μM | |
| 反応時間 | ||
| 実験の流れ | ||
| 動物実験 | 動物モデル | Male athymic Nu/Nu mice |
| 投薬量 | 20 mg/kg | |
| 投与方法 | i.p. | |
|
| Sorafenib enhanced the function of myeloid-derived suppressor cells in hepatocellular carcinoma by facilitating PPARα-mediated fatty acid oxidation [ Mol Cancer, 2025, 24(1):34] | PubMed: 39876004 |
| Macrophage-derived VISTA engages with LRIG1 and hinders gut epithelial repair in colitis [ Cell Mol Immunol, 2025, 10.1038/s41423-025-01338-y] | PubMed: 40883589 |
| Nutrient deficiency-induced downregulation of SNX1 inhibits ferroptosis through PPARs-ACSL1/4 axis in colorectal cancer [ Apoptosis, 2025, 30(5-6):1391-1409] | PubMed: 40095264 |
| Formononetin ameliorates depression-like behaviors through rebalancing microglia M1/M2 polarization and inhibiting NLRP3 inflammasome: involvement of activating PPARα-mediated autophagy [ Mol Med, 2025, 31(1):153] | PubMed: 40275171 |
| Berberine Attenuates Nonalcoholic Hepatic Steatosis by Regulating Lipid Droplet-Associated Proteins: In Vivo, In Vitro and Molecular Evidence [ J Cell Mol Med, 2025, 29(7):e70524] | PubMed: 40194991 |
| FNDC4 Prevents Aging-Related Cardiac Dysfunction: By Restoring AMPKα/PPARα-Dependent Mitochondrial Function [ JACC Basic Transl Sci, 2025, 10(7):101222] | PubMed: 40464727 |
| Suppression of ferroptosis by vitamin A or radical-trapping antioxidants is essential for neuronal development [ Nat Commun, 2024, 15(1):7611] | PubMed: 39218970 |
| CD24 negativity reprograms mitochondrial metabolism to PPARα and NF-κB-driven fatty acid β-oxidation in triple-negative breast cancer [ Cancer Lett, 2024, 587:216724] | PubMed: 38373689 |
| Tubular CPT1A deletion minimally affects aging and chronic kidney injury [ JCI Insight, 2024, 9(6)e171961] | PubMed: 38516886 |
| PIM1 drives lipid droplet accumulation to promote proliferation and survival in prostate cancer [ Oncogene, 2024, 43(6):406-419] | PubMed: 38097734 |
長期の保管のために-20°Cの下で製品を保ってください。
人間や獣医の診断であるか治療的な使用のためにでない。
各々の製品のための特定の保管と取扱い情報は、製品データシートの上で示されます。大部分のSelleck製品は、推薦された状況の下で安定です。製品は、推薦された保管温度と異なる温度で、時々出荷されます。長期の保管のために必要とされてそれと異なる温度で、多くの製品は、短期もので安定です。品質を維持するが、夜通しの積荷のために最も経済的な貯蔵状況を用いてあなたの送料を保存する状況の下に、製品が出荷されることを、我々は確実とします。製品の受領と同時に、製品データシートの上で貯蔵推薦に従ってください。